Veterinary Molecular Diagnostics Market
Veterinary Molecular Diagnostics Market Study by PCR Kits, INAAT Kits, Microarray Kits, and DNA Sequencing Kits for Livestock Animals and Companion Animals from 2024 to 2034
Analysis of Veterinary Molecular Diagnostics Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Veterinary Molecular Diagnostics Market Outlook (2024 to 2034)
Revenue from the global veterinary molecular diagnostics market size is estimated to reach US$ 211 million in 2024. The market has been analyzed to climb to a value of US$ 463.3 million by the end of 2034, expanding at a CAGR of 7.5% between 2024 and 2034.
- According to a 2020 animal research study conducted by the World Health Organization, zoonotic origins account for approximately 60% to 70% of infectious diseases in humans.
Veterinary molecular diagnostics tests samples from animals. Advancements in the farm animal sector, as well as societal attitudes toward pet animals, have boosted demand for quick and dependable diagnostic techniques. Molecular diagnostics is perfectly suited to this increased demand. Veterinary molecular diagnostics focuses on pathogen detection, identification, and genotyping.
Key Market Growth Drivers
- Growing awareness among veterinarians and pet owners about the advantages of molecular diagnostics in early disease detection and personalized treatment is propelling veterinary molecular diagnostics market growth.
- Supportive regulatory frameworks and guidelines for animal healthcare, as well as initiatives promoting responsible pet ownership and animal welfare, are driving the use of molecular diagnostic tests in veterinary practices.
- Technologically advanced diagnostic products and solutions to detect various diseases in pets and farm animals are benefitting market players.
- Increasing milk and meat consumption, discovery of new diseases among animals, and the transmission of infectious diseases such as anthrax and plague from animals to humans are some of the major factors setting the veterinary molecular diagnostic market trends.
- The global veterinary diagnosis market is also being driven by increased farm animal or pet adoption in developed and developing countries, as well as the rising availability of medical information on the Internet.
- Abundance of readily available information makes pet owners extremely perceptive, increasing the demand for high-quality veterinary care.
| Report Attribute | Details |
|---|---|
| Veterinary Molecular Diagnostics Market Size (2024 E) | US$ 211 Million |
| Projected Market Value (2034 F) | US$ 436.3 Million |
| Global Market Growth Rate (2024 to 2034) | 7.5% CAGR |
| Latin America Market Growth Rate (2024 to 2034) | 6.9% CAGR |
| North America Market Growth Rate (2034) | 7.3% CAGR |
| Veterinary Hospitals Segment Value (2024) | US$ 105.2 Million |
| Livestock Animals Segment Value (2024) | US$ 149.8 Million |
| Key Companies Profiled | Thermo Fisher Scientific Inc.; IDEXX Laboratories, Inc.; Qiagen N.V.; Neogen Corporation; ID. Vet; bioMérieux SA; INDICAL BIOSCIENCE GmbH; Veterinary Molecular Diagnostics, Inc. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Will Rising Adoption of Pets Create Higher Demand for Veterinary Molecular Diagnostics?
“Increasing Animal Health Expenditure across Regions”
Stringent regulations and consumer demand for safe animal-derived products, such as meat and dairy, are driving the need for rigorous disease monitoring and testing. Continuous advancements in molecular diagnostic technologies are enhancing the accuracy, speed, and range of diagnostic capabilities available to veterinary professionals.
- According to a study published by the University of Calgary in June 2021 to investigate Echinococcus multilocularis infections in domestic dogs to determine their potential role in zoonotic transmission, Echinococcus multilocularis, a parasitic helminth of the northern hemisphere (Alberta, Canada), typically cycles through definitive and intermediate hosts.
In urban areas, domestic dogs can become hosts for this parasite, which could pose a significant risk to humans due to their proximity.
- The Canadian government's article on reportable diseases in terrestrial animals, which was updated in February 2021, listed several diseases that affect animals, including companion animals in the region.
Increase in animal health expenditure is expected to drive the growth of the market, as a sizable proportion of pet owners are expected to use advanced diagnostic modalities for various disease conditions in animals.
- According to the American Pet Products Association's April 2022 estimates, total American pet industry expenditure was set to reach US$ 123.6 billion in 2021, up from US$ 103.6 billion the previous year.
“Rising Adoption of Microarray Technology in Veterinary Diagnostics”
Increasing use of PCR tests such as real-time PCR, assembly PCR, hot-start PCR, methylation-specific PCR (MSP), and nested PCR are some other factors driving growth in molecular diagnostics. Furthermore, RT-PCR technology is low-cost and allows for real-time monitoring of the expression levels of multiple genetic messages. Emergence of biochips and their increasing applications in the identification of infectious diseases is a major driver for microarray technology, which is also contributing to the expansion of the veterinary molecular diagnostics market size.
What Main Challenges are Impacting Market Growth?
“Shortage of Skilled Veterinarians and Limited Understanding of Veterinary Diseases”
Skilled pathologists and veterinarians are in short supply, particularly in developing countries across Latin America (Brazil, Mexico, Argentina), Asia Pacific (India, China), and parts of Africa. This shortage creates a substantial gap between supply and demand in the veterinary profession.
Critical obstacle to global market growth is the inadequate understanding of the epidemiology of endemic veterinary diseases. For instance, the economic impact of insufficient epidemiological knowledge is evident in outbreaks like the Newcastle disease virus (NDV) affecting poultry and other animals. Rapid mutations in various vNDV genotypes exacerbate these knowledge gaps.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
North America is expected to hold a significant veterinary molecular diagnostics market share of 41% in 2024, driven by factors such as rising expenditures on animal health insurance, a surge in both clinical and non-clinical visits to veterinary practices, expanding private clinical services for companion animals and equines, a marked increase in pet adoption rates among households, and growth in both companion and livestock animal populations.
How is the Market for Veterinary Molecular Diagnostics Shaping Up in the United States?
“Increased Animal Product Consumption Necessitating Animal Health Monitoring for Food Safety”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 73 Million |
| Growth Rate (2024 to 2034) | 7.2% CAGR |
| Projected Value (2034F) | US$ 147 Million |
Due to increased consumption of meat, milk, and eggs, along with the widespread adoption of pets and farm animals, rigorous diagnosis of animals before consumption is essential in the United States.
- The World Animal Foundation estimates that pneumonia infects 80% of all hog meat consumed globally. According to the CDC, Salmonella zoonotic outbreaks were prevalent in the United States in 2021. Salmonella bacteria infected both chicken and beef.
- The American Society for the Prevention of Cruelty shelters approximately 6.3 million pet animals each year. Cats account for 3.2 million, while dogs make up 3.1 million. Every year, approximately 2.1 million cats and 2 million dogs in the United States are adopted from shelters, increasing pet healthcare spending.
Why is There Growing Interest in Improved Veterinary Diagnostics in Brazil?
“Need for Accurate Pathogen Identification in Veterinary Medicine”
| Attribute | Brazil |
|---|---|
| Market Value (2024E) | US$ 9 Million |
| Growth Rate (2024 to 2034) | 7% CAGR |
| Projected Value (2034F) | US$ 17 Million |
Brazil's diverse geography and climate expose it to a wide array of animal diseases. Molecular diagnostics offer rapid and accurate identification of pathogens, enabling veterinarians to diagnose and treat diseases more effectively. In Brazil, there is an increasing focus among companies and researchers on developing innovative veterinary diagnostics. This emphasis on research and development is one of the key veterinary molecular diagnostics market trends in the country.
Category-wise Insights
The veterinary molecular diagnostics market is categorized into product type, species type, and disease type, and its end users are veterinary hospitals, clinical laboratories, and veterinary research institutes.
PCR kits, INAAT kits, and microarray kits are identified as product types. PCR is set to capture 50% market share in 2024. In terms of species, the livestock segment is poised to hold 70% of the market share in 2024. In addition, Newcastle disease is set to hold a market share of 31.5%, followed by influenza with 26.9% share.
Why is Prioritization of Livestock Animal Diagnostics Important?
“Vulnerability of Livestock to Disease Outbreaks Necessitating Prevention Measures”
| Attribute | Livestock Animals |
|---|---|
| Segment Value (2024E) | US$ 149.8 Million |
| Growth Rate (2024 to 2034) | 7.6% CAGR |
| Projected Value (2034F) | US$ 311.4 Million |
Livestock animals are projected to constitute 71% share of the global market in 2024. Across the globe, people consume animal-derived foods like fish, meat, eggs, poultry, and dairy for balanced nutrition.
Diagnosing animal diseases plays a crucial role in understanding their causes, treatment, and effective management and prevention. The COVID-19 pandemic highlighted the vulnerability of the animal community to outbreaks, which can swiftly escalate to humans. Hence, diagnostics for livestock animals are pivotal in propelling global market expansion.
Why is Demand for PCR Kits Gaining Traction?
“Rapid and Accurate Diagnostic Capabilities of PCR Kits”
| Attribute | PCR Kits |
|---|---|
| Segment Value (2024E) | US$ 107.5 Million |
| Growth Rate (2024 to 2034) | 7.8% CAGR |
| Projected Value (2034F) | US$ 227.6 Million |
PCR kits are poised to account for a substantial 51% market share in 2024 due to their ability to produce precise and reliable results in less time. Polymerase chain reaction (PCR) swiftly identifies bacteria and viruses that grow slowly in cell cultures. PCR provides faster and more precise results compared to traditional methods. Diagnosing animal diseases bridges the gap between disease onset and effective treatment planning, with PCR kits occupying a significant market share.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
Key players in the veterinary molecular diagnostics market are investing heavily in R&D to develop advanced molecular diagnostic technologies tailored for veterinary applications. They are entering into partnerships with veterinary clinics, academic institutions, and research organizations to drive innovation and expand their customer base.
- In September 2022, bioMérieux, a leading in vitro diagnostics company, and BrightInsight, a regulated digital health solution company, announced a collaboration to manufacture and supply Clinical Digital Solutions for Diagnostics, which will aid in clinical decision-making in the pet disease area.
- In January 2022, IDEXX Laboratories, Inc. expanded its reference laboratory menu of tests and services, allowing veterinarians to better address the challenges of cancer diagnosis and treatment. The expansion includes a liquid biopsy test that uses next-generation DNA sequencing technology to detect canine cancers.
Fact.MR provides detailed information about the price points of leading providers of veterinary molecular diagnostics positioned across the world, sales growth, production capacity, and technological advancements, in this recently updated market report.
Segmentation of Veterinary Molecular Diagnostics Market Research
-
By Product Type :
- PCR Kits
- INAAT Kits
- Microarray Kits
- DNA Sequencing Kits
-
By Species :
- Livestock Animals
- Companion Animals
-
By Disease :
- Anaplasma spp.
- Ehrlichia spp.
- New Castle Disease
- Influenza
- Porcine Reproductive & Respiratory Syndrome
-
By End User :
- Veterinary Hospitals
- Clinical Laboratories
- Veterinary Research Institutes
-
By Region :
- North America
- Western Europe
- Eastern Europe
- East Asia
- South Asia & Pacific
- Latin America
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 6.1. Species
- 6.2. Product Type
- 6.3. Disease
- 6.4. End User
- 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Species
- 7.1. Livestock Animals
- 7.2. Companion Animals
- 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Product Type
- 8.1. PCR Kits
- 8.2. INAAT Kits
- 8.3. Microarray Kits
- 8.4. DNA Sequencing Kits
- 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Disease
- 9.1. Anaplasma spp.
- 9.2. Ehrlichia spp.
- 9.3. New Castle Disease
- 9.4. Influenza
- 9.5. Porcine Reproductive & Respiratory Syndrome
- 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by End User
- 10.1. Veterinary Hospitals
- 10.2. Clinical Laboratories
- 10.3. Veterinary Research Institutes
- 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region
- 11.1. North America
- 11.2. Latin America
- 11.3. Western Europe
- 11.4. Eastern Europe
- 11.5. East Asia
- 11.6. South Asia & Pacific
- 11.7. Middle East & Africa
- 12. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 13. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 14. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 15. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 16. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 17. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 18. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 19. Sales Forecast 2024 to 2034 by Species, Product Type, Disease, End User, and Region for 30 Countries
- 20. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 21. Company Profile
- 21.1. Thermo Fisher Scientific Inc.
- 21.2. IDEXX Laboratories, Inc.
- 21.3. Qiagen N.V.
- 21.4. Neogen Corporation
- 21.5. ID. Vet
- 21.6. bioMérieux SA
- 21.7. INDICAL BIOSCIENCE GmbH
- 21.8. Veterinary Molecular Diagnostics, Inc.
- 22. Assumptions and Acronyms Used
- 23. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Species, 2019 to 2023
Table 02: Global Market Value (US$ Mn) Analysis, by Species, 2024 to 2034
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Species, 2024 to 2034
Table 04: Global Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 05: Global Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 07: Global Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023
Table 08: Global Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034
Table 10: Global Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 11: Global Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 13: Global Market Value (US$ Mn) Analysis, by Region, 2019 to 2023
Table 14: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034
Table 15: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034
Table 16: North America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 17: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 19: North America Market Value (US$ Mn) Analysis, by Species, 2019 to 2023
Table 20: North America Market Value (US$ Mn) Analysis, by Species, 2024 to 2034
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Species, 2024 to 2034
Table 22: North America Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 23: North America Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 25: North America Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023
Table 26: North America Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034
Table 27: North America Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034
Table 28: North America Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 29: North America Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 30: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 31: Latin America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 32: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 34: Latin America Market Value (US$ Mn) Analysis, by Species, 2019 to 2023
Table 35: Latin America Market Value (US$ Mn) Analysis, by Species, 2024 to 2034
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by Species, 2024 to 2034
Table 37: Latin America Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 38: Latin America Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 39: Latin America Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 40: Latin America Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023
Table 41: Latin America Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034
Table 42: Latin America Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034
Table 43: Latin America Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 44: Latin America Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 45: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 46: Western Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 47: Western Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 48: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 49: Western Europe Market Value (US$ Mn) Analysis, by Species, 2019 to 2023
Table 50: Western Europe Market Value (US$ Mn) Analysis, by Species, 2024 to 2034
Table 51: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Species, 2024 to 2034
Table 52: Western Europe Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 53: Western Europe Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 54: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 55: Western Europe Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023
Table 56: Western Europe Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034
Table 57: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034
Table 58: Western Europe Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 59: Western Europe Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 60: Western Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 61: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 62: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 63: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 64: Eastern Europe Market Value (US$ Mn) Analysis, by Species, 2019 to 2023
Table 65: Eastern Europe Market Value (US$ Mn) Analysis, by Species, 2024 to 2034
Table 66: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Species, 2024 to 2034
Table 67: Eastern Europe Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 68: Eastern Europe Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 69: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 70: Eastern Europe Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023
Table 71: Eastern Europe Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034
Table 72: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034
Table 73: Eastern Europe Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 74: Eastern Europe Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 75: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 76: East Asia Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 77: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 78: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 79: East Asia Market Value (US$ Mn) Analysis, by Species, 2019 to 2023
Table 80: East Asia Market Value (US$ Mn) Analysis, by Species, 2024 to 2034
Table 81: East Asia Market Value (US$ Mn) Opportunity Analysis, by Species, 2024 to 2034
Table 82: East Asia Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 83: East Asia Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 84: East Asia Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 85: East Asia Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023
Table 86: East Asia Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034
Table 87: East Asia Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034
Table 88: East Asia Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 89: East Asia Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 90: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 91: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 92: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 93: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 94: South Asia & Pacific Market Value (US$ Mn) Analysis, by Species, 2019 to 2023
Table 95: South Asia & Pacific Market Value (US$ Mn) Analysis, by Species, 2024 to 2034
Table 96: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Species, 2024 to 2034
Table 97: South Asia & Pacific Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 98: South Asia & Pacific Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 99: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 100: South Asia & Pacific Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023
Table 101: South Asia & Pacific Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034
Table 102: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034
Table 103: South Asia & Pacific Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 104: South Asia & Pacific Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 105: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 106: MEA Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 107: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 108: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 109: MEA Market Value (US$ Mn) Analysis, by Species, 2019 to 2023
Table 110: MEA Market Value (US$ Mn) Analysis, by Species, 2024 to 2034
Table 111: MEA Market Value (US$ Mn) Opportunity Analysis, by Species, 2024 to 2034
Table 112: MEA Market Value (US$ Mn) Analysis, by Product Type, 2019 to 2023
Table 113: MEA Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 114: MEA Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 115: MEA Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023
Table 116: MEA Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034
Table 117: MEA Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034
Table 118: MEA Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 119: MEA Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 120: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 04: Global Market Incremental $ Opportunity, 2024 to 2034
Figure 05: Global Market Share and BPS Analysis by Species, 2024 & 2034
Figure 06: Global Market Y-o-Y Growth Projections by Species, 2024 to 2034
Figure 07: Global Market Attractiveness Analysis by Species, 2024 to 2034
Figure 08: Global Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 09: Global Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 11: Global Market Share and BPS Analysis by Disease, 2024 & 2034
Figure 12: Global Market Y-o-Y Growth Projections by Disease, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by Disease, 2024 to 2034
Figure 14: Global Market Share and BPS Analysis by End User, 2024 & 2034
Figure 15: Global Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by End User, 2024 to 2034
Figure 17: Global Market Share and BPS Analysis by Region, 2024 & 2034
Figure 18: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034
Figure 19: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 20: North America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 21: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 22: North America Market Value Y-o-Y Growth and Forecast, 2034
Figure 23: North America Market Incremental $ Opportunity, 2024 to 2034
Figure 24: North America Market Share Analysis by Country, 2024 & 2034
Figure 25: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 26: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 27: North America Market Share and BPS Analysis by Species, 2024 & 2034
Figure 28: North America Market Y-o-Y Growth Projections by Species, 2024 to 2034
Figure 29: North America Market Attractiveness Analysis by Species, 2024 to 2034
Figure 30: North America Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 31: North America Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 32: North America Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 33: North America Market Share and BPS Analysis by Disease, 2024 & 2034
Figure 34: North America Market Y-o-Y Growth Projections by Disease, 2024 to 2034
Figure 35: North America Market Attractiveness Analysis by Disease, 2024 to 2034
Figure 36: North America Market Share and BPS Analysis by End User, 2024 & 2034
Figure 37: North America Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 38: North America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 39: Latin America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 40: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 41: Latin America Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 42: Latin America Market Incremental $ Opportunity, 2024 to 2034
Figure 43: Latin America Market Share Analysis by Country, 2024 & 2034
Figure 44: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 45: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 46: Latin America Market Share and BPS Analysis by Species, 2024 & 2034
Figure 47: Latin America Market Y-o-Y Growth Projections by Species, 2024 to 2034
Figure 48: Latin America Market Attractiveness Analysis by Species, 2024 to 2034
Figure 49: Latin America Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 50: Latin America Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 51: Latin America Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 52: Latin America Market Share and BPS Analysis by Disease, 2024 & 2034
Figure 53: Latin America Market Y-o-Y Growth Projections by Disease, 2024 to 2034
Figure 54: Latin America Market Attractiveness Analysis by Disease, 2024 to 2034
Figure 55: Latin America Market Share and BPS Analysis by End User, 2024 & 2034
Figure 56: Latin America Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 57: Latin America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 58: Western Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 59: Western Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 60: Western Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 61: Western Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 62: Western Europe Market Share Analysis by Country, 2024 & 2034
Figure 63: Western Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 64: Western Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 65: Western Europe Market Share and BPS Analysis by Species, 2024 & 2034
Figure 66: Western Europe Market Y-o-Y Growth Projections by Species, 2024 to 2034
Figure 67: Western Europe Market Attractiveness Analysis by Species, 2024 to 2034
Figure 68: Western Europe Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 69: Western Europe Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 70: Western Europe Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 71: Western Europe Market Share and BPS Analysis by Disease, 2024 & 2034
Figure 72: Western Europe Market Y-o-Y Growth Projections by Disease, 2024 to 2034
Figure 73: Western Europe Market Attractiveness Analysis by Disease, 2024 to 2034
Figure 74: Western Europe Market Share and BPS Analysis by End User, 2024 & 2034
Figure 75: Western Europe Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 76: Western Europe Market Attractiveness Analysis by End User, 2024 to 2034
Figure 77: Eastern Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 78: Eastern Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 79: Eastern Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 80: Eastern Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 81: Eastern Europe Market Share Analysis by Country, 2024 & 2034
Figure 82: Eastern Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 83: Eastern Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 84: Eastern Europe Market Share and BPS Analysis by Species, 2024 & 2034
Figure 85: Eastern Europe Market Y-o-Y Growth Projections by Species, 2024 to 2034
Figure 86: Eastern Europe Market Attractiveness Analysis by Species, 2024 to 2034
Figure 87: Eastern Europe Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 88: Eastern Europe Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 89: Eastern Europe Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 90: Eastern Europe Market Share and BPS Analysis by Disease, 2024 & 2034
Figure 91: Eastern Europe Market Y-o-Y Growth Projections by Disease, 2024 to 2034
Figure 92: Eastern Europe Market Attractiveness Analysis by Disease, 2024 to 2034
Figure 93: Eastern Europe Market Share and BPS Analysis by End User, 2024 & 2034
Figure 94: Eastern Europe Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 95: Eastern Europe Market Attractiveness Analysis by End User, 2024 to 2034
Figure 96: East Asia Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 97: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 98: East Asia Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 99: East Asia Market Incremental $ Opportunity, 2024 to 2034
Figure 100: East Asia Market Share Analysis by Country, 2024 & 2034
Figure 101: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 102: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 103: East Asia Market Share and BPS Analysis by Species, 2024 & 2034
Figure 104: East Asia Market Y-o-Y Growth Projections by Species, 2024 to 2034
Figure 105: East Asia Market Attractiveness Analysis by Species, 2024 to 2034
Figure 106: East Asia Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 107: East Asia Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 108: East Asia Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 109: East Asia Market Share and BPS Analysis by Disease, 2024 & 2034
Figure 110: East Asia Market Y-o-Y Growth Projections by Disease, 2024 to 2034
Figure 111: East Asia Market Attractiveness Analysis by Disease, 2024 to 2034
Figure 112: East Asia Market Share and BPS Analysis by End User, 2024 & 2034
Figure 113: East Asia Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 114: East Asia Market Attractiveness Analysis by End User, 2024 to 2034
Figure 115: South Asia & Pacific Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 116: South Asia & Pacific Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 117: South Asia & Pacific Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 118: South Asia & Pacific Market Incremental $ Opportunity, 2024 to 2034
Figure 119: South Asia & Pacific Market Share Analysis by Country, 2024 & 2034
Figure 120: South Asia & Pacific Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 121: South Asia & Pacific Market Attractiveness Analysis by Country, 2024 to 2034
Figure 122: South Asia & Pacific Market Share and BPS Analysis by Species, 2024 & 2034
Figure 123: South Asia & Pacific Market Y-o-Y Growth Projections by Species, 2024 to 2034
Figure 124: South Asia & Pacific Market Attractiveness Analysis by Species, 2024 to 2034
Figure 125: South Asia & Pacific Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 126: South Asia & Pacific Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 127: South Asia & Pacific Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 128: South Asia & Pacific Market Share and BPS Analysis by Disease, 2024 & 2034
Figure 129: South Asia & Pacific Market Y-o-Y Growth Projections by Disease, 2024 to 2034
Figure 130: South Asia & Pacific Market Attractiveness Analysis by Disease, 2024 to 2034
Figure 131: South Asia & Pacific Market Share and BPS Analysis by End User, 2024 & 2034
Figure 132: South Asia & Pacific Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 133: South Asia & Pacific Market Attractiveness Analysis by End User, 2024 to 2034
Figure 134: MEA Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 135: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 136: MEA Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 137: MEA Market Incremental $ Opportunity, 2024 to 2034
Figure 138: MEA Market Share Analysis by Country, 2024 & 2034
Figure 139: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 140: MEA Market Attractiveness Analysis by Country, 2024 to 2034
Figure 141: MEA Market Share and BPS Analysis by Species, 2024 & 2034
Figure 142: MEA Market Y-o-Y Growth Projections by Species, 2024 to 2034
Figure 143: MEA Market Attractiveness Analysis by Species, 2024 to 2034
Figure 144: MEA Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 145: MEA Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 146: MEA Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 147: MEA Market Share and BPS Analysis by Disease, 2024 & 2034
Figure 148: MEA Market Y-o-Y Growth Projections by Disease, 2024 to 2034
Figure 149: MEA Market Attractiveness Analysis by Disease, 2024 to 2034
Figure 150: MEA Market Share and BPS Analysis by End User, 2024 & 2034
Figure 151: MEA Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 152: MEA Market Attractiveness Analysis by End User, 2024 to 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the veterinary molecular diagnostics market in 2024?
The global veterinary molecular diagnostics market is estimated at US$ 211 million in 2024.
What are the sales projections for veterinary molecular diagnostics?
The global market is forecasted to expand at a CAGR of 7.5% to reach US$ 436.3 million by 2034.
Which country has a significant market for veterinary molecular diagnostics?
The United States is estimated to reach a market value of US$ 73 million in 2024.
What is the market size of veterinary molecular diagnostics in Brazil?
The Brazilian market is forecasted to reach US$ 17 million by the end of 2034.
How much market share do veterinary research institutes account for?
Veterinary research institutes are expected to account for 14.4% of the global market share in 2024.
What is the share of Chile in the Latin America market?
Chile is estimated to account for 26.5% market share in Latin America in 2024.
Who are the market leaders in the business of veterinary molecular diagnostics?
IDEXX Laboratories, Inc., Qiagen N.V., Neogen Corporation, ID. Vet, bioMérieux SA, and INDICAL BIOSCIENCE GmbH are some of the key players in the market.
Veterinary Molecular Diagnostics Market